Hormone Replacement Therapy After a Diagnosis of Breast Cancer

Abstract

Get full access to this article

View all access options for this article.

References

1. Carpenter

. Hot flashes in postmenopausal women treated for breast carcinoma. Prevalence, severity, correlates, management and relation to quality of life. Cancer 1998; 82: 1682–1691.

2. Vassilopoulou-Sellin

Zolinski

Estrogen replacement therapy in women with breast cancer: a survey of patient attitudes. Am J Medical Sciences 1992; 304: 145–149.

3. Hulka

. Steroid hormones and breast cancer. Cancer 1994; 74 suppl 3: 1111–24

4. Thomas

. A prospective study of endogenous serum hormone concentrations and breast cancer risk in postmenopausal women on the island of Guernsey. Br J Cancer 1997; 76: 401–405.

5. Lønning

. Influence of plasma oestrogen levels on the length of the disease-free interval in postmenopausal women with breast cancer. Br Cancer Res Treat 1996; 39: 335–341.

6. Jordan

. Tamoxifen in the treatment of breast cancer. NEJM 1998; 339: 1609–1618.

7. Nachtigall

. Incidence of breast cancer in a 22 year study of women receiving estrogen-progestin replacement therapy. Obstet Gynaecol 1992; 80: 827–30.

8. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis from 51 epidemiological studies. Lancet 1997; 350: 1047–60.

9. Willis

. Estrogen replacement therapy and risk of fatal breast cancer in a cohort of postmenopausal women in the Untied States. Cancer Causes Control 1996; 7: 449–457.

10.

10. Marsden

. Hormone replacement therapy in women with previous breast cancer. Trends Endocrinology Metabolism 1998; 9: 32–38.